BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26442127)

  • 1. The predictive role of NLR and PLR for solid non-AIDS defining cancer incidence in HIV-infected subjects: a MASTER cohort study.
    Raffetti E; Donato F; Castelli F; Maggiolo F; Carosi G; Quiros-Roldan E
    Infect Agent Cancer; 2015; 10():34. PubMed ID: 26442127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic inflammation-based scores and mortality for all causes in HIV-infected patients: a MASTER cohort study.
    Raffetti E; Donato F; Casari S; Castelnuovo F; Sighinolfi L; Bandera A; Maggiolo F; Ladisa N; di Pietro M; Fornabaio C; Digiambenedetto S; Quiros-Roldan E
    BMC Infect Dis; 2017 Mar; 17(1):193. PubMed ID: 28264665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neutrophil to lymphocyte and platelet to lymphocyte ratios as biomarkers for lung cancer development.
    Sanchez-Salcedo P; de-Torres JP; Martinez-Urbistondo D; Gonzalez-Gutierrez J; Berto J; Campo A; Alcaide AB; Zulueta JJ
    Lung Cancer; 2016 Jul; 97():28-34. PubMed ID: 27237024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab?
    Ulas A; Avci N; Kos T; Cubukcu E; Olmez OF; Bulut N; Degirmenci M
    J BUON; 2015; 20(3):714-22. PubMed ID: 26214622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of inflammatory biomarkers in HIV-infected patients with a first diagnosis of hepatocellular carcinoma: A single-center study.
    Quiros-Roldan E; Properzi M; Amadasi S; Raffetti E; Ferraresi A; Biasi L; Focà E; Castelli F
    J Med Virol; 2019 Feb; 91(2):241-248. PubMed ID: 30216474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High neutrophil-to-lymphocyte ratios confer poor prognoses in patients with small cell lung cancer.
    Liu D; Huang Y; Li L; Song J; Zhang L; Li W
    BMC Cancer; 2017 Dec; 17(1):882. PubMed ID: 29268698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
    Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios during chemoradiation predict for survival and pathologic complete response in trimodality esophageal cancer patients.
    Hyder J; Boggs DH; Hanna A; Suntharalingam M; Chuong MD
    J Gastrointest Oncol; 2016 Apr; 7(2):189-95. PubMed ID: 27034785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-to-lymphocyte ratio predicts mortality better than neutrophil-to-lymphocyte ratio in hemodialysis patients.
    Yaprak M; Turan MN; Dayanan R; Akın S; Değirmen E; Yıldırım M; Turgut F
    Int Urol Nephrol; 2016 Aug; 48(8):1343-1348. PubMed ID: 27118565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non-small cell lung cancer patients.
    Wu G; Yao Y; Bai C; Zeng J; Shi D; Gu X; Shi X; Song Y
    Thorac Cancer; 2015 May; 6(3):275-87. PubMed ID: 26273373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios are independent prognostic factors for surgically resected gastrointestinal stromal tumors.
    Goh BK; Chok AY; Allen JC; Quek R; Teo MC; Chow PK; Chung AY; Ong HS; Wong WK
    Surgery; 2016 Apr; 159(4):1146-56. PubMed ID: 26688506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio with the Risk of Thromboembolism and Mortality in Patients with Cancer.
    Grilz E; Posch F; Königsbrügge O; Schwarzinger I; Lang IM; Marosi C; Pabinger I; Ay C
    Thromb Haemost; 2018 Nov; 118(11):1875-1884. PubMed ID: 30296815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer.
    Lian L; Xia YY; Zhou C; Shen XM; Li XL; Han SG; Zheng Y; Mao ZQ; Gong FR; Wu MY; Chen K; Tao M; Li W
    Cancer Biomark; 2015; 15(6):899-907. PubMed ID: 26444485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101.
    He CB; Lin XJ
    PLoS One; 2017; 12(3):e0174769. PubMed ID: 28355305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio for acute deep vein thrombosis after total joint arthroplasty: a retrospective study.
    Yao C; Zhang Z; Yao Y; Xu X; Jiang Q; Shi D
    J Orthop Surg Res; 2018 Feb; 13(1):40. PubMed ID: 29482566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation.
    Bojaxhiu B; Templeton AJ; Elicin O; Shelan M; Zaugg K; Walser M; Giger R; Aebersold DM; Dal Pra A
    Radiat Oncol; 2018 Nov; 13(1):216. PubMed ID: 30400969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic Inflammatory Response in Predicting Prostate Cancer: The Diagnostic Value of Neutrophil-To-Lymphocyte Ratio.
    Adhyatma KP; Prapiska FF; Siregar GP; Warli SM
    Open Access Maced J Med Sci; 2019 May; 7(10):1628-1630. PubMed ID: 31210812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients.
    Graziano V; Grassadonia A; Iezzi L; Vici P; Pizzuti L; Barba M; Quinzii A; Camplese A; Di Marino P; Peri M; Veschi S; Alberti S; Gamucci T; Di Gioacchino M; De Tursi M; Natoli C; Tinari N
    Breast; 2019 Apr; 44():33-38. PubMed ID: 30611095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.
    Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z
    Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.